EUCTR2010-022521-15-AT进行中（未招募）不适用
Prospektive, klinische 4-Arm Pilotstudie zur Dosisfindung der kombi-nierten Anwendung von P.L.E.A.S.E. mit 5% topischen Imiquimod ver-sus Standardapplikation von 5% topischem Imiquimod bei Basaliomen
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Primäre Basaliome
- •Basaliomrezidive
- •Inkomplett exzidierte Basaliome
- •aller klinischen Formen
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Basaliome an schwer zugänglichen oder nicht flachen Körperstellen, welche ein flaches Aufsetzen des Lasers verhindern
- •Basalioma < 5cm vom Auge, in den Capillitiumhaaren und Genitale
- •persönliche oder familiäre Keloidneigung
- •Alter <18, > 85
- •Allergie gegen IMQ
- •Frauen im gebährfähigen Alter
- •Schwangerschaft und Stillzeit
研究者
相似试验
进行中（未招募）
不适用
An open-label, 28-day multiple dose pilot study to evaluate the effects on lung oxidative stress, safety and pharmacokinetics of TA-270 in patients with chronic obstructive pulmonary disease (COPD).EUCTR2009-009096-35-GBActivus Pharma Co., Ltd12
进行中（未招募）
1 期
A study to test the effectiveness and safety of bacteria called Bifidobacterium breve in patients with COVID-19 infectionsSymptoms of Covid-19 infectionMedDRA version: 20.0Level: LLTClassification code 10061986Term: SARSSystem Organ Class: 100000004862EUCTR2020-001597-30-GB4D pharma plc90
招募中
不适用
Pilot study on the efficacy and safty of low-dose tocilizumab therapy in elderly RA patientsRheumatoid arthritisJPRN-UMIN000008185Kyushu University Beppu Hospital Department of Metabolism, Hematology and Rheumatic Diseases (DMHRDs)10
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Switching to iGlarLixi in People with Type 2 Diabetes Mellitus Uncontrolled on Once or Twice Daily Premixed Insulin Regimencontrolled Type 2 Diabetes MellitusMedDRA version: 21.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2021-003711-25-CZSanofi-Aventis Recherche & Développement168
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Switching to iGlarLixi in People with Type 2 Diabetes Mellitus Uncontrolled on Once or Twice Daily Premixed Insulin RegimeEUCTR2021-003711-25-PLSanofi-Aventis Recherche & Développement168